In The Cancer Genome Atlas (TCGA) dataset, 14% of invasive bladder cancers have mutations in CDKN1A encoding the cyclin-dependent kinase inhibitor p21CIP1 [24]. This evidence concerns the gene CDKN3 and urinary bladder cancer.